Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia.
The homeostatic integrity of skin epidermis is maintained by a balance between keratinocyte proliferation, on one hand, and terminal differentiation combined with outward migration and shedding, on the other. Perturbation of this balance in favor of proliferation can result in hyperplasia and, potentially, tumorigenesis. We have previously described a reversible transgenic mouse model of epidermal neoplasia in which expression of an acutely regulatable form of Myc, MycERTAM, is targeted to epidermis via the involucrin promoter. In this model, sustained activation of MycERTAM induces a complex neoplastic lesion involving marked hyperplasia of less-differentiated suprabasal cells, angiogenesis and overt papillomatosis. Subsequent deactivation of MycERTAM triggers complete papilloma regression. Here, we provide evidence that Myc-induced papillomas are self-limiting because of the eventual differentiation of MycERTAM-expressing keratinocytes. Thus, keratinocyte differentiation eventually prevails over Myc-induced proliferation. We also show that regression of Myc-induced papillomas following MycERTAM deactivation occurs through a combination of growth arrest and irreversible differentiation. Finally, we demonstrate that transient deactivation of Myc is sufficient to expel keratinocytes irreversibly from the proliferative compartment and render them refractory to the mitogenic influence of subsequent Myc reactivation. Such observations illustrate the potential utility of even short-term inhibition of oncogenic lesions in the treatment of cancer.
Flores
Ignacio
I
Cancer Research Institute, University of California at San Francisco, 2340 Sutter St, San Francisco, CA 94143-0875, USA.
Murphy
Daniel J
DJ
Swigart
Lamorna Brown
LB
Knies
Ulrike
U
Evan
Gerard I
GI
D000818:Animals; D002455:Cell Division; D018450:Disease Progression; D016259:Genes, myc / Q000502:physiology*; D006965:Hyperplasia; D020287:In Situ Nick-End Labeling; D015603:Keratinocytes / Q000166:cytology; D019394:Ki-67 Antigen / Q000032:analysis; D051379:Mice; D008808:Mice, Inbred CBA; D010212:Papilloma / Q000209:etiology / Q000235:genetics / Q000473:pathology; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000209:etiology / Q000235:genetics* / Q000473:pathology
D019394:Ki-67 Antigen